MARATTO

article · Life Sciences

SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Parathyroid Disorders and Treatments
  • Heterotopic Ossification and Related Conditions
  • Cell Adhesion Molecules Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.lfs.2026.124339

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.